A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Elsulfavirine-15N, D5 - Request Quote

Picture of Elsulfavirine-15N, D5

Elsulfavirine-15N, D5

SZ CAT No:SZ-E142D01
CAS No
NA
Mol.F.
C24H12D5BrCl2FN215NO5S
Mol.Wt.
635.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Elsulfavirine-15N, D5 is chemically N-((4-(2-(4-bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl)acetamido)-3-chlorophenyl)sulfonyl)propan-d5-amide-N-15N. Elsulfavirine-15N, D5 is supplied with detailed characterization data compliant with regulatory guideline. Elsulfavirine-15N, D5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Elsulfavirine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Elsulfavirine-15N, D5

Purchase Elsulfavirine-15N, D5

Elsulfavirine-15N, D5 suppliers

Elsulfavirine-15N, D5 manufacturers

Elsulfavirine-15N, D5 price

Order Elsulfavirine-15N, D5

Enquire Elsulfavirine-15N, D5

Elsulfavirine-15N, D5 cost

Elsulfavirine-15N, D5 Supplier

Elsulfavirine-15N, D5 Distributor

Elsulfavirine-15N, D5 for Method Validation

Elsulfavirine Reference Standard

Elsulfavirine-15N, D5 for ANDA Filing

Elsulfavirine-15N, D5 for Forced Degradation Studies

Elsulfavirine-15N, D5 Identification Standards

Elsulfavirine-15N, D5 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,